摘要
艾滋病免疫重建不良是临床难点问题,中医药治疗有一定优势。但是缺乏本病病因病机、诊断标准、诊疗方案等行业指引规范或指南,临床高质量研究报道较少,有效的医疗机构制剂作用机制不清等问题,建议整合优势研究力量,协同攻关,开发机制明确、疗效确切的中药新药,进一步提高艾滋病诊疗水平。
Incomplete immune reconstitution(IIR)of acquired immune deficiency syndrome(AIDS)is a difficult clinical problem,and traditional Chinese medicine has certain advantages.However,there is a lack of industry norms or guidelines on the etiology and pathogenesis,diagnostic criteria,diagnosis and treatment schemes of the disease.Few high-quality clinical research has been reported with clear mechanism.It is suggested to integrate advantageous research groups to jointly deal with those key problems,and get some new Chinese herb medicines with clear mechanism so as to further improve the diagnosis and treatment of AIDS.
作者
巩仪凡
刘志斌
GONG Yifan;LIU Zhibin(The First Clinical Medical School,Henan University of Chinese Medicine,Zhengzhou 450000,China;The First Affiliated Hospital of Henan University of CM,Zhengzhou 450000,China)
出处
《中华中医药杂志》
CSCD
北大核心
2023年第12期5639-5642,共4页
China Journal of Traditional Chinese Medicine and Pharmacy
基金
国家科技重大专项子课题(No.2017ZX10205502002,No.2017ZX10205502003)
河南省中医药科学研究专项课题(No.20-21ZYZD03,No.2021JDZY085)。
关键词
获得性免疫缺陷综合征
免疫重建不良
中医药
病因病机
Acquired immune deficiency syndrome(AIDS)
Incomplete immune reconstitution(IIR)
Traditional Chinese medicine
Etiology and pathogenesis